Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
295.19
+3.74 (1.28%)
At close: Aug 21, 2026, 4:00 PM EDT
295.15
-0.04 (-0.01%)
After-hours: Aug 21, 2026, 7:38 PM EDT

CRL Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-238.46-144.3422.2474.62486.23390.98
Depreciation & Amortization
353.28378.81324.64314.12303.87265.54
Loss (Gain) From Sale of Assets
142.9-3.380.660.96-123.41-25.03
Asset Writedown & Restructuring Costs
348.16424.08276.2341.915.820.73
Loss (Gain) on Equity Investments
5.0824.9112.91-97.8326.7830.42
Stock-Based Compensation
83.0671.0869.8972.0573.6271.47
Provision & Write-off of Bad Debts
56.0614.7718.236.711.66
Other Operating Activities
-12.24-33.6743.6-37.79-7.41-17.92
Change in Accounts Receivable
-32.9135.7421.61-33.43-150.57-26.63
Change in Inventory
8.92-48.7816.8-62.3-78.52-25.16
Change in Accounts Payable
7.92.87-14.27-20.43-2.6544.9
Change in Unearned Revenue
-34.31-23.4925.13-37.3188.123.52
Change in Other Net Operating Assets
-54.2447.74-79.651.09-8.9246.31
Operating Cash Flow
582.15737.65734.58683.9619.64760.8
Operating Cash Flow Growth
-26.07%0.42%7.41%10.37%-18.55%39.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-211.54-219.15-232.97-318.53-324.73-228.77
Cash Acquisitions
-467.25--5.48-194.79-283.39-1,293
Divestitures
176.5617.44--163.28122.69
Investment in Securities
-5.74-10.97-11.19-47.55-153.73-39.02
Other Investing Activities
1.723.364.55-2.29-9.350.26
Investing Cash Flow
-506.25-209.32-245.09-563.16-607.92-1,438

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,2281,082776.352,9526,951
Long-Term Debt Repaid
--1,349-1,494-851.68-2,933-6,243
Net Debt Issued (Repaid)
321.89-121.78-412.19-75.3219.79708.24
Issuance of Common Stock
2.330.7123.8825.625.1145.65
Repurchase of Common Stock
-324.07-360.67-119.18-24.16-38.65-40.71
Other Financing Activities
-21.57-54.98-43.44-11.64-48.65-40.58
Financing Cash Flow
-21.42-536.73-550.93-85.52-42.4672.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.3618.83-17.478.0425.5817.73
Net Cash Flow
55.8410.43-78.9143.27-5.113.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
370.61518.49501.61365.37294.91532.03
Free Cash Flow Growth
-35.94%3.37%37.29%23.89%-44.57%40.00%
Free Cash Flow Margin
9.27%12.91%12.38%8.85%7.42%15.03%
Free Cash Flow Per Share
7.5910.469.727.105.7510.35
Levered Free Cash Flow
468.86572.38489.63214.21303.66629.6
Unlevered Free Cash Flow
535.27639.28568.56299.65340.72675.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
99.8101.72123.45132.1100.7570.78
Cash Income Tax Paid
63.43119.64126.190.475.9175.44
Change in Working Capital
-104.6314.08-30.33-102.38-152.5542.94
SEC Filings: 10-K · 10-Q